Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 May;18(2):281-91.
doi: 10.1016/j.cld.2013.12.001. Epub 2014 Feb 25.

Pathophysiology of portal hypertension

Yasuko Iwakiri  1
Affiliations
Review

Pathophysiology of portal hypertension

Yasuko Iwakiri. Clin Liver Dis. 2014 May.

Abstract

Portal hypertension is a major complication of liver disease that results from a variety of pathologic conditions that increase the resistance to the portal blood flow into the liver. As portal hypertension develops, the formation of collateral vessels and arterial vasodilation progresses, which results in increased blood flow to the portal circulation. Hyperdynamic circulatory syndrome develops, leading to esophageal varices or ascites. This article summarizes the factors that increase (1) intrahepatic vascular resistance and (2) the blood flow in the splanchnic and systemic circulations in liver cirrhosis. In addition, the future directions of basic/clinical research in portal hypertension are discussed.

Keywords: Cirrhosis; Fibrosis; Hyperdynamic circulation; Lymphatic system; Nitric oxide; Splenomegaly.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Portal hypertension leads to the development of the hyperdynamic circulatory syndrome, characterized by decreased mean arterial pressure (MAP), decreased systemic vascular resistance (SVR) and increased cardiac index (CI).
Figure 2
Figure 2. Activated hepatic stellate cells (HSCs) in liver cirrhosis increase intrahepatic vascular resistance
Quiescent HSCs are vitamin A storage cells and found in normal livers. In response to fibrogenic stimuli, such as transforming growth factor beta, HSCs are activated to become myofibroblasts, which exhibit a contractile and fibrogenic (collagen-producing) phenotype. These activated HSCs, located underneath liver sinusoidal endothelial cells, exert a contractile effect on the hepatic microcirculation, resulting in an increase in intrahepatic resistance.
See this image and copyright information in PMC

References

    1. Bosch J. Vascular deterioration in cirrhosis: the big picture. J Clin Gastroenterol. 2007;41(Suppl 3):S247–53. - PubMed
    1. Iwakiri Y, Groszmann RJ. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatology. 2006;43:S121–31. - PubMed
    1. Rockey DC. Cell and molecular mechanisms of increased intrahepatic resistance and hemodynamic correlates. Humana Press Inc; Totowa, NJ: 2005.
    1. Pinzani M, Vizzutti F. Anatomy and vascular biology of the cells in the portal circulation. Humana Press Inc; Totowa, NJ: 2005.
    1. Wiest R, Groszmann RJ. The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough. Hepatology. 2002;35:478–91. - PubMed

Publication types